KITE Crosses Above Average Analyst Target
June 09, 2017 at 10:06 AM EDT
In recent trading, shares of Kite Pharma Inc (KITE) have crossed above the average analyst 12-month target price of $82.50, changing hands for $86.67/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..